Cargando…
Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study
ACE2 has been established as the main receptor for SARS-CoV-2. Since other human coronaviruses are known to use co-receptors for viral cell entry, it has been suggested that DPP4 (CD26) could be a potential additional binding target or co-receptor, supported by early molecular docking simulation stu...
Autores principales: | Cameron, Kirsten, Rozano, Lina, Falasca, Marco, Mancera, Ricardo L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269389/ https://www.ncbi.nlm.nih.gov/pubmed/34209788 http://dx.doi.org/10.3390/ijms22137001 |
Ejemplares similares
-
The Molecular Docking of MAX Fungal Effectors with Plant HMA Domain-Binding Proteins
por: Rozano, Lina, et al.
Publicado: (2023) -
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
por: Wang, Nianshuang, et al.
Publicado: (2013) -
Dipeptidyl peptidase-4 (DPP-4; CD26)
Publicado: (2013) -
CD26/DPP-4 in Chronic Myeloid Leukemia
por: Sicuranza, Anna, et al.
Publicado: (2022) -
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)